NEP has been proposed as a potential therapeutic for the treatment of Alzheimer’s disease because of its activity in cleaving the amyloid-beta (Aβ) peptide [2,3] and studies have shown that increasing the level of brain NEP in animal models significantly reduces brain Aβ [4–7]. The gene discussed is MME; the disease is early-onset autosomal dominant Alzheimer disease.